1. Home
  2. VCEL

VCEL

Vericel Corporation

as 04-01-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Founded: 1989 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: N/A IPO Year: 1997
Target Price: $63.00 AVG Volume (30 days): 402.9K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.20 EPS Growth: N/A
52 Week Low/High: $39.12 - $63.00 Next Earning Date: 05-07-2025
Revenue: $237,224,000 Revenue Growth: 20.10%
Revenue Growth (this year): 23.23% Revenue Growth (next year): 24.41%

VCEL Daily Stock ML Predictions

Stock Insider Trading Activity of Vericel Corporation (VCEL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Colangelo Dominick VCEL President and CEO Mar 12 '25 Sell $46.05 53,183 $2,448,810.97 259,997
Halpin Michael VCEL Chief Operating Officer Mar 3 '25 Sell $49.52 10,000 $495,200.00 15,539
Hopper Jonathan Mark VCEL Chief Medical Officer Mar 3 '25 Sell $49.53 10,000 $495,300.00 66,101
Mara Joseph Anthony Jr VCEL Chief Financial Officer Mar 3 '25 Sell $49.53 9,000 $445,770.00 13,967
Hagen Heidi VCEL Director Mar 3 '25 Sell $49.53 9,000 $445,770.00 28,650
Flynn Sean C. VCEL Chief Legal Officer Feb 24 '25 Sell $52.07 1,669 $86,904.83 756
SIEGAL JONATHAN VCEL Principal Accounting Officer Feb 24 '25 Sell $52.07 1,137 $59,203.59 1,206
Flynn Sean C. VCEL Chief Legal Officer Feb 20 '25 Sell $57.32 3,835 $219,822.20 756
SIEGAL JONATHAN VCEL Principal Accounting Officer Feb 18 '25 Sell $56.72 1,710 $96,991.20 1,206
MCLAUGHLIN KEVIN F VCEL Director Feb 12 '25 Sell $55.45 7,000 $388,250.00 11,900

Share on Social Networks: